Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.

Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Omori K, Tsuchida K, Miya A, Shigesawa I, Tsuchida K, Yanagiya S, Kameda H, Yokoyama H, Taneda S, Kurihara Y, Aoki S, Nishimoto N, Atsumi T, Miyoshi H

Open source

DOI: 10.1111/jdi.13498
Published: 2021 Aug
Container: Journal of diabetes investigation
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdi.13498,
  title = {Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.},
  author = {Cho KY and Nomoto H and Nakamura A and Kawata S and Sugawara H and Takeuchi J and Nagai S and Omori K and Tsuchida K and Miya A and Shigesawa I and Tsuchida K and Yanagiya S and Kameda H and Yokoyama H and Taneda S and Kurihara Y and Aoki S and Nishimoto N and Atsumi T and Miyoshi H},
  year = {2021},
  journal = {Journal of diabetes investigation},
  doi = {10.1111/jdi.13498},
  url = {https://doi.org/10.1111/jdi.13498}
}

RIS

TY  - JOUR
TI  - Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
AU  - Cho KY
AU  - Nomoto H
AU  - Nakamura A
AU  - Kawata S
AU  - Sugawara H
AU  - Takeuchi J
AU  - Nagai S
AU  - Omori K
AU  - Tsuchida K
AU  - Miya A
AU  - Shigesawa I
AU  - Tsuchida K
AU  - Yanagiya S
AU  - Kameda H
AU  - Yokoyama H
AU  - Taneda S
AU  - Kurihara Y
AU  - Aoki S
AU  - Nishimoto N
AU  - Atsumi T
AU  - Miyoshi H
PY  - 2021
JO  - Journal of diabetes investigation
DO  - 10.1111/jdi.13498
UR  - https://doi.org/10.1111/jdi.13498
ER  -

APA

KY, C., H, N., A, N., S, K., H, S., J, T., S, N., K, O., K, T., A, M., I, S., K, T., S, Y., H, K., H, Y., S, T., Y, K., S, A., N, N., T, A., & H, M. (2021). Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.. Journal of diabetes investigation. https://doi.org/10.1111/jdi.13498

Source records

pubmed · retrieved 2026-09-26T20:56:35.046Z
europe-pmc · retrieved 2026-09-26T20:56:35.059Z
doaj · retrieved 2026-09-26T20:56:35.062Z